# ERIBULIN MESYLATE
> **ANDA219054** · Abbreviated New Drug Application (Generic) · Sponsor: XGEN PHARMS · Approved 2026-03-16
## Drug
- **FDA Application Number:** ANDA219054
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERIBULIN MESYLATE
- **Generic name:** ERIBULIN MESYLATE
- **Active ingredients:** ERIBULIN MESYLATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** XGEN PHARMS
- **Manufacturer:** XGen Pharmaceuticals DJB, Inc.
- **First approval:** 2026-03-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219054)
---
*AI Analytics · CC0 1.0*